Combining Enzalutamide with Radium-223 Significantly Improves rPFS as First-Line Therapy for Patients with mCRPC By Ogkologos - August 27, 2025 507 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PEACE-3 study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR FDA Approves Combination of Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf for HER2-positive Breast... July 2, 2020 Real-World Increase in Biomarker Testing in Lung Cancer Patients, Registry Study... March 23, 2022 Forging Military Partnerships to Empower the Cancer Research Enterprise March 27, 2018 Coronavirus reports – Part 7: “I’m more concerned about the second... November 24, 2020 Load more HOT NEWS Epigenetic Changes Pinpointed as the Cause of Some GISTs EMA Recommends Granting a Marketing Authorisation for Duvelisib Breast Cancer Survivor Driven from Her Home by Noxious Gases from... Intratumoural Administration of the Oncolytic Herpes Virus Shows Survival Benefit and...
